Previous Close | 5.15 |
Open | 5.20 |
Bid | 5.17 x 600 |
Ask | 5.22 x 600 |
Day's Range | 5.14 - 5.34 |
52 Week Range | 4.82 - 9.07 |
Volume | |
Avg. Volume | 3,320,221 |
Market Cap | 1.07B |
Beta (5Y Monthly) | 1.92 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
In this article, we’re going to take a look at 13 best biotech stocks to buy under $20. To see more stocks that made the list, you can skip ahead and jump straight to the top 5 best biotech stocks to buy under $20. When it comes to investing, few industries are as exciting to […]
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q4 2023 Earnings Call Transcript February 26, 2024 BioCryst Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.28 EPS, expectations were $-0.24. BioCryst Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, […]
BioCryst Pharmaceuticals ( NASDAQ:BCRX ) Full Year 2023 Results Key Financial Results Revenue: US$331.4m (up 22% from...